Beijing Wandong Medical Technology Co Ltd (600055) - Net Assets

Latest as of September 2025: CN¥4.79 Billion CNY ≈ $701.38 Million USD

Based on the latest financial reports, Beijing Wandong Medical Technology Co Ltd (600055) has net assets worth CN¥4.79 Billion CNY (≈ $701.38 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.70 Billion ≈ $833.75 Million USD) and total liabilities (CN¥904.54 Million ≈ $132.36 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Beijing Wandong Medical Technology Co Lt to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.79 Billion
% of Total Assets 84.12%
Annual Growth Rate 17.82%
5-Year Change 105.0%
10-Year Change 585.87%
Growth Volatility 58.27

Beijing Wandong Medical Technology Co Ltd - Net Assets Trend (1994–2024)

This chart illustrates how Beijing Wandong Medical Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 600055 total assets for the complete picture of this company's asset base.

Annual Net Assets for Beijing Wandong Medical Technology Co Ltd (1994–2024)

The table below shows the annual net assets of Beijing Wandong Medical Technology Co Ltd from 1994 to 2024. For live valuation and market cap data, see 600055 stock market capitalisation.

Year Net Assets Change
2024-12-31 CN¥4.88 Billion
≈ $713.80 Million		 +1.19%
2023-12-31 CN¥4.82 Billion
≈ $705.41 Million		 +2.34%
2022-12-31 CN¥4.71 Billion
≈ $689.31 Million		 +88.19%
2021-12-31 CN¥2.50 Billion
≈ $366.28 Million		 +5.19%
2020-12-31 CN¥2.38 Billion
≈ $348.20 Million		 +8.97%
2019-12-31 CN¥2.18 Billion
≈ $319.54 Million		 +8.23%
2018-12-31 CN¥2.02 Billion
≈ $295.23 Million		 +6.09%
2017-12-31 CN¥1.90 Billion
≈ $278.29 Million		 +2.38%
2016-12-31 CN¥1.86 Billion
≈ $271.82 Million		 +161.18%
2015-12-31 CN¥711.21 Million
≈ $104.07 Million		 +4.85%
2014-12-31 CN¥678.31 Million
≈ $99.26 Million		 +0.63%
2013-12-31 CN¥674.04 Million
≈ $98.63 Million		 +4.55%
2012-12-31 CN¥644.71 Million
≈ $94.34 Million		 +5.49%
2011-12-31 CN¥611.17 Million
≈ $89.43 Million		 +4.02%
2010-12-31 CN¥587.57 Million
≈ $85.98 Million		 +5.16%
2009-12-31 CN¥558.76 Million
≈ $81.76 Million		 +11.28%
2008-12-31 CN¥502.13 Million
≈ $73.48 Million		 +5.60%
2007-12-31 CN¥475.52 Million
≈ $69.58 Million		 +5.59%
2006-12-31 CN¥450.36 Million
≈ $65.90 Million		 +5.19%
2005-12-31 CN¥428.15 Million
≈ $62.65 Million		 -4.38%
2004-12-31 CN¥447.78 Million
≈ $65.52 Million		 +5.72%
2003-12-31 CN¥423.54 Million
≈ $61.98 Million		 +9.55%
2002-12-31 CN¥386.60 Million
≈ $56.57 Million		 +9.44%
2001-12-31 CN¥353.26 Million
≈ $51.69 Million		 +3.26%
2000-12-31 CN¥342.10 Million
≈ $50.06 Million		 +2.93%
1999-12-31 CN¥332.36 Million
≈ $48.63 Million		 +41.20%
1998-12-31 CN¥235.38 Million
≈ $34.44 Million		 +13.61%
1997-12-31 CN¥207.18 Million
≈ $30.32 Million		 +287.99%
1996-12-31 CN¥53.40 Million
≈ $7.81 Million		 +34.07%
1995-12-31 CN¥39.83 Million
≈ $5.83 Million		 +11.78%
1994-12-31 CN¥35.63 Million
≈ $5.21 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Beijing Wandong Medical Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 105831880100.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.06 Billion 22.20%
Common Stock CN¥703.06 Million 14.75%
Other Components CN¥3.01 Billion 63.05%
Total Equity CN¥4.77 Billion 100.00%

Beijing Wandong Medical Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Beijing Wandong Medical Technology Co Ltd ranked by their market capitalization.

Company Market Cap
Daou Tech
KO:023590
 $1.47 Billion
Chengdu RML Technology Co. Ltd.
SHE:301050
 $1.47 Billion
ProPetro Holding Corp
NYSE:PUMP
 $1.47 Billion
Nomad Foods Limited
F:0NH
 $1.47 Billion
Paramount Group Inc
NYSE:PGRE
 $1.46 Billion
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
 $1.46 Billion
Deutsche EuroShop AG
F:DEQ
 $1.46 Billion
Focus Technology Co Ltd
SHE:002315
 $1.46 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Beijing Wandong Medical Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,711,473,658 to 4,767,546,579, a change of 56,072,921 (1.2%).
  • Net income of 157,351,003 contributed positively to equity growth.
  • Dividend payments of 91,397,937 reduced retained earnings.
  • Other comprehensive income decreased equity by 241,029,479.
  • Other factors increased equity by 231,149,334.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥157.35 Million +3.3%
Dividends Paid CN¥91.40 Million -1.92%
Other Comprehensive Income CN¥-241.03 Million -5.06%
Other Changes CN¥231.15 Million +4.85%
Total Change CN¥- 1.19%

Book Value vs Market Value Analysis

This analysis compares Beijing Wandong Medical Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.10x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 193.15x to 2.10x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-12-31 CN¥0.07 CN¥14.24 x
1995-12-31 CN¥0.08 CN¥14.24 x
1996-12-31 CN¥0.11 CN¥14.24 x
1997-12-31 CN¥0.43 CN¥14.24 x
1998-12-31 CN¥0.47 CN¥14.24 x
1999-12-31 CN¥0.67 CN¥14.24 x
2000-12-31 CN¥0.69 CN¥14.24 x
2001-12-31 CN¥0.71 CN¥14.24 x
2002-12-31 CN¥0.76 CN¥14.24 x
2003-12-31 CN¥0.84 CN¥14.24 x
2004-12-31 CN¥0.88 CN¥14.24 x
2005-12-31 CN¥0.88 CN¥14.24 x
2006-12-31 CN¥0.92 CN¥14.24 x
2007-12-31 CN¥0.97 CN¥14.24 x
2008-12-31 CN¥1.02 CN¥14.24 x
2009-12-31 CN¥1.14 CN¥14.24 x
2010-12-31 CN¥1.20 CN¥14.24 x
2011-12-31 CN¥1.22 CN¥14.24 x
2012-12-31 CN¥1.32 CN¥14.24 x
2013-12-31 CN¥1.36 CN¥14.24 x
2014-12-31 CN¥1.39 CN¥14.24 x
2015-12-31 CN¥2.35 CN¥14.24 x
2016-12-31 CN¥4.63 CN¥14.24 x
2017-12-31 CN¥3.38 CN¥14.24 x
2018-12-31 CN¥3.59 CN¥14.24 x
2019-12-31 CN¥3.90 CN¥14.24 x
2020-12-31 CN¥4.26 CN¥14.24 x
2021-12-31 CN¥4.47 CN¥14.24 x
2022-12-31 CN¥7.09 CN¥14.24 x
2023-12-31 CN¥6.75 CN¥14.24 x
2024-12-31 CN¥6.78 CN¥14.24 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Beijing Wandong Medical Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.30%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 10.32%
  • • Asset Turnover: 0.28x
  • • Equity Multiplier: 1.15x
  • Recent ROE (3.30%) is below the historical average (11.47%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 54.46% 21.49% 0.87x 2.90x CN¥15.84 Million
1995 52.68% 18.58% 0.92x 3.09x CN¥17.00 Million
1996 43.96% 19.35% 0.91x 2.50x CN¥18.13 Million
1997 14.71% 22.54% 0.47x 1.39x CN¥9.76 Million
1998 13.33% 18.19% 0.53x 1.37x CN¥7.58 Million
1999 9.42% 14.77% 0.46x 1.39x CN¥-1.86 Million
2000 7.83% 9.41% 0.53x 1.58x CN¥-7.22 Million
2001 9.33% 9.80% 0.65x 1.46x CN¥-2.31 Million
2002 9.17% 8.67% 0.65x 1.62x CN¥-3.04 Million
2003 8.45% 7.23% 0.71x 1.64x CN¥-6.24 Million
2004 7.60% 6.71% 0.57x 1.98x CN¥-10.17 Million
2005 4.15% 3.55% 0.58x 2.02x CN¥-24.74 Million
2006 6.78% 5.77% 0.66x 1.78x CN¥-14.31 Million
2007 5.96% 5.26% 0.60x 1.89x CN¥-18.99 Million
2008 5.73% 4.70% 0.59x 2.06x CN¥-21.15 Million
2009 12.46% 10.04% 0.70x 1.76x CN¥13.52 Million
2010 7.24% 6.96% 0.60x 1.74x CN¥-16.01 Million
2011 6.60% 6.77% 0.58x 1.68x CN¥-20.52 Million
2012 5.39% 4.72% 0.67x 1.71x CN¥-29.33 Million
2013 6.55% 5.70% 0.67x 1.72x CN¥-22.93 Million
2014 3.85% 3.47% 0.60x 1.84x CN¥-41.08 Million
2015 5.77% 4.93% 0.62x 1.90x CN¥-29.55 Million
2016 3.99% 8.80% 0.37x 1.23x CN¥-107.67 Million
2017 5.92% 12.34% 0.38x 1.26x CN¥-75.32 Million
2018 7.81% 16.06% 0.39x 1.24x CN¥-43.12 Million
2019 8.08% 17.19% 0.38x 1.23x CN¥-40.02 Million
2020 9.67% 19.50% 0.40x 1.25x CN¥-7.61 Million
2021 7.65% 15.84% 0.40x 1.20x CN¥-56.41 Million
2022 3.81% 15.64% 0.21x 1.14x CN¥-285.17 Million
2023 4.00% 15.25% 0.23x 1.15x CN¥-282.61 Million
2024 3.30% 10.32% 0.28x 1.15x CN¥-319.40 Million

Industry Comparison

This section compares Beijing Wandong Medical Technology Co Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,964,235,365
  • Average return on equity (ROE) among peers: 8.35%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Beijing Wandong Medical Technology Co Ltd (600055) CN¥4.79 Billion 54.46% 0.19x $1.47 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022) $1.03 Billion 22.10% 0.17x $449.34 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) $10.07 Billion 15.85% 0.50x $4.35 Billion
Double Medical Technology Inc (002901) $3.18 Billion 11.21% 0.39x $2.60 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) $615.62 Million 6.75% 0.04x $571.62 Million
Lepu Medical Tech Beijing (300003) $6.58 Billion 18.53% 1.30x $3.90 Billion
INKON Life Technology Co Ltd (300143) $1.48 Billion 0.71% 0.25x $1.25 Billion
Edan Instruments Inc (300206) $1.16 Billion 1.16% 0.17x $1.28 Billion
Guangdong Biolight Meditech Co Ltd (300246) $1.50 Billion 1.47% 0.62x $696.90 Million
Beijing Leadman Biochemistry Co Ltd (300289) $1.38 Billion -3.70% 0.18x $533.36 Million
Sinocare Inc (300298) $2.65 Billion 9.46% 0.24x $1.35 Billion

About Beijing Wandong Medical Technology Co Ltd

SHG:600055 China Medical Devices
Market Cap
$1.47 Billion
CN¥10.01 Billion CNY
Market Cap Rank
#7522 Global
#1828 in China
Share Price
CN¥14.24
Change (1 day)
-1.45%
52-Week Range
CN¥13.84 - CN¥18.71
All Time High
CN¥34.38
Categories
Companies in China Medical Devices
About

Beijing Wandong Medical Technology Co.,Ltd. engages in the research, development, manufactures, sales, and after-sale services of digital imaging equipment in China. It operates through two segments Medical Equipment Sales Business; and Medical Services and Others. The company provides digital X radiography system (DR), including panorama DR; magnetic resonance imaging system (MRI) for clinical m… Read more